Aristo Bio-Tech and Lifescience Limited (NSE:ARISTO)
India
· Delayed Price · Currency is INR 131.00
-0.10 (-0.08%)
At close: Jul 11, 2025
NSE:ARISTO Revenue
In the fiscal year ending March 31, 2025, Aristo Bio-Tech and Lifescience had annual revenue of 3.18B INR with 29.76% growth.
Revenue
3.18B
Revenue Growth
+36.31%
P/S Ratio
0.27
Revenue / Employee
63.62M
Employees
50
Market Cap
874.12M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,561.48B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Hindustan Unilever | 631.21B |